Covid: Oxford-AstraZeneca jab protection against South Africa variant 'limited', study suggests
Published
A small study points to limited Oxford jab protection against mild disease caused by S Africa variant.
Full ArticlePublished
A small study points to limited Oxford jab protection against mild disease caused by S Africa variant.
Full ArticleSouth Africa has put its roll-out of the jab on hold after a study showed "disappointing" results against its mutant strain.
The Oxford/AstraZeneca vaccine is less effective against the South Africa variant of COVID-19, researchers have found.